The CanSino vaccine is currently undergoing Phase 3 trials and has been granted military approval in China, which is more limited than emergency authorisation.
Tianjin-based CanSino emerged as one of the fastest movers on a vaccine in May when it became the first firm to publish a full scientific study on its early human trials.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS